New York Life Investment Management’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
25,869
-1,136
| -4% | -$50.1K | 0.01% | 621 |
|
|
2025
Q1 | $997K | Buy |
27,005
+338
| +1% | +$12.5K | 0.01% | 646 |
|
|
2024
Q4 | $888K | Sell |
26,667
-3,647
| -12% | -$121K | 0.01% | 683 |
|
|
2024
Q3 | $787K | Sell |
30,314
-3,550
| -10% | -$92.1K | 0.01% | 742 |
|
|
2024
Q2 | $761K | Buy |
33,864
+2,192
| +7% | +$49.3K | 0.01% | 741 |
|
|
2024
Q1 | $752K | Sell |
31,672
-3,891
| -11% | -$92.3K | 0.01% | 740 |
|
|
2023
Q4 | $853K | Sell |
35,563
-1,383
| -4% | -$33.2K | 0.01% | 695 |
|
|
2023
Q3 | $807K | Buy |
36,946
+17,425
| +89% | +$381K | 0.01% | 675 |
|
|
2023
Q2 | $373K | Buy |
+19,521
| New | +$373K | ﹤0.01% | 1099 |
|